Form 4: Topsoe Acquires Shares in IGM Biosciences Through RSU Vesting

Christina Teng Topsoe, a director of IGM Biosciences, acquired shares through the vesting of restricted stock units and also has indirect ownership through Topsoe Holding A/S and Pillarcater LLC.

Summary

• On September 30, 2024, Christina Teng Topsoe, a director of IGM Biosciences, acquired 2,687 shares of common stock through the vesting of restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of IGM Biosciences' common stock each.
• The acquisition was part of a quarterly retainer paid in common stock under the Issuer's Outside Director Compensation Policy.
• Topsoe also has indirect ownership of 10,400,564 shares through Topsoe Holding A/S and 9,800 shares through Pillarcater LLC.
• Following the transaction, Topsoe directly owns 48,980 shares of IGM Biosciences common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction disclosure, not indicative of significant positive or negative news.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures for insiders, providing transparency into their transactions and ownership positions. This filing indicates routine compensation in the form of stock.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates